About GENES

GENES is a cutting-edge start-up Medical service in the Kingdom of Saudi Arabia

About GENES :

GENES is a cutting-edge start-up Medical service in the Kingdom of Saudi Arabia, specializing in molecular genetic testing and genomics and utilizing the latest advancements in NGS, bioinformatics, and genomic data analysis to provide actionable insights for better decision-making in patient care.

The services of GENES encompass a wide range of molecular genetic tests, including targeted genetic panels, whole genome sequencing, whole exome sequencing, RNA sequencing, and leukemia-associated translocation testing.

Genetic testing services provide high-quality genetic testing for cancer, rare diseases, and genetic predispositions. Cancer genomic testing offers molecular profiling of cancer that focuses on identifying mutations, genetic translocations, and therapeutic targets. These services cater to both researchers and clinicians, with the ultimate goal of improving patient outcomes through precision medicine.

Our Vision :

We aim to become a leader in the field of molecular genetics and genomics in the region, setting a new standard for precision healthcare. By harnessing the power of molecular genetic testing, we are committed to advancing healthcare outcomes, promoting early disease detection, and enabling tailored treatments for individuals based on their unique genetic makeup.

With the growing need for genomic research and personalized medicine, our start-up Medical service is at the forefront of this dynamic field, poised to make significant contributions to the healthcare landscape of Saudi Arabia and beyond.

Our Mission :

Our mission is to revolutionize healthcare by providing advanced genetic diagnostics and solutions that empower individuals and clinicians with critical insights into genetic disorders, cancer genomics, and personalized medicine.

At the heart of our innovation is Next-Generation Sequencing (NGS), a powerful technology that allows us to explore the genomic landscape in unprecedented detail. By leveraging NGS and other state-of-the-art molecular techniques, we deliver high-quality, accurate, and timely results for genetic testing in various domains, including cancer genomics, rare genetic diseases, and hereditary conditions.

Our Services

Our goal is to satisfy our customers to provide the best service

Single Gene Disorders

These genetic conditions are caused by mutations in a single gene. They follow Mendelian inheritance patterns and could be autosomal dominant, autosomal recessive, or X-linked. Examples include cystic fibrosis (autosomal recessive; affects lungs and digestive system), sickle cell anemia (autosomal recessive; causes abnormal red blood cells), Huntington’s Disease (autosomal dominant; leads to progressive brain disorder), and hemophilia (X-linked recessive; impairs blood clotting).

Carrier Detection

Carrier detection identifies individuals who carry one copy of a mutated gene for a recessive genetic disorder. Carriers usually show no symptoms but can pass the gene to offspring. This test is important for autosomal recessive and X-linked conditions. The DNA test is performed to assess genetic risk in couples. Examples include cystic fibrosis, thalassemia, and Tay-Sachs disease.

Prenatal Genetic Testing

Prenatal genetic testing involves testing a fetus for genetic abnormalities before birth. It helps detect inherited disorders or chromosomal anomalies early in pregnancy. The test informs parental decisions, and guides early medical care or intervention. Diagnostic tests include amniocentesis, chorionic villus sampling, and the new non-invasive blood testing that detects cell-free fetal DNA (cfDNA) in the maternal circulation.

APOE Genotyping

APOE (Apolipoprotein E) genotyping identifies variants of the APOE gene, which influence lipid metabolism and risk for certain diseases, especially Alzheimer’s. The allele ε2 may reduce Alzheimer's risk, while the most common allele ε3 has only a neutral risk. The allele ε4 is associated with higher risk of late-onset Alzheimer's disease. The test is used to assess genetic risk for Alzheimer’s, guide personalized prevention strategies, and evaluate cardiovascular risk. The DNA test is done via a blood sample or a saliva sample.

Our Address

ُKSA , Abha

Email Us

drfatimagenes@outlook.com

Call Us

0561070735